Skip to main content
. 2020 Dec 12;11(12):1060. doi: 10.1038/s41419-020-03282-3

Fig. 1. FZD5 is principally expressed in TNBC and associated with unfavorable prognosis.

Fig. 1

A TCGA (TNBC: 115; non-TNBC: 858) and GSE2603 (TNBC: 25; non-TNBC: 71) databases were interrogated for FZD5 expression. FZD5 mRNA levels were compared between TNBC and non-TNBC. **P < 0.01, ***P < 0.001, vs. non-TNBC. B FZD5 expression in 18 TNBC and 24 non-TNBC was detected by immunohistochemistry. Staining of some representative samples was shown. H: high; M: median; L: low; N: negative. Scalebar: 25 μm. C The association of FZD5 with OS, RFS, DMFS, and PPS was analyzed in Kaplan–Meier plotter website. D, E Go analysis of the gene pathways differentially expressed between FZD5-high and FZD5-low breast cancer samples in TCGA database was performed. Four representative GSEA-enrichment plots were shown.